These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12908508)

  • 1. Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use.
    André F; Van Damme P; Safary A; Banatvala J
    Expert Rev Vaccines; 2002 Jun; 1(1):9-23. PubMed ID: 12908508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of hepatitis A by Havrix: a review.
    Van Herck K; Van Damme P
    Expert Rev Vaccines; 2005 Aug; 4(4):459-71. PubMed ID: 16117704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of 10 years of marketing experience with Chinese domestic inactivated hepatitis A vaccine Healive®.
    Wu JY; Liu Y; Chen JT; Xia M; Zhang XM
    Hum Vaccin Immunother; 2012 Dec; 8(12):1836-44. PubMed ID: 23032165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
    Kaltenböck A; Dubischar-Kastner K; Eder G; Jilg W; Klade C; Kollaritsch H; Paulke-Korinek M; von Sonnenburg F; Spruth M; Tauber E; Wiedermann U; Schuller E
    Vaccine; 2009 Jul; 27(33):4483-9. PubMed ID: 19486955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open, prospective, randomized study comparing the immunogenicity and safety of two inactivated hepatitis A pediatric vaccines in toddlers, children and adolescents in China.
    Li RC; Li Y; Yi N; Huang L; Wan Z; Zhang Y; Rasuli A
    Pediatr Infect Dis J; 2013 Feb; 32(2):e77-81. PubMed ID: 23334341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects.
    Wallace MR; Brandt CJ; Earhart KC; Kuter BJ; Grosso AD; Lakkis H; Tasker SA
    Clin Infect Dis; 2004 Oct; 39(8):1207-13. PubMed ID: 15486846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the immunogenicity and safety of 2 kinds of inactivated hepatitis A vaccine vaccinated in 1-3 years old children].
    Fu Y; Li ZL; Lao SJ; Wang M; Chen QB; Chen SJ; Li JG; Zhang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):551-2. PubMed ID: 15231151
    [No Abstract]   [Full Text] [Related]  

  • 9. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children.
    Zhang ZL; Zhu XJ; Wang X; Liang M; Sun J; Liu Y; Gao ZG; Wu JY; Dong XJ; Liu RK; Chen JT; Zhang YQ; Wang W; Zhang LP; Yin W
    Vaccine; 2012 Jun; 30(27):4028-33. PubMed ID: 22537990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
    Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and effectiveness of the new inactivated hepatitis A virus vaccine.
    Furesz J; Scheifele DW; Palkonyay L
    CMAJ; 1995 Feb; 152(3):343-8. PubMed ID: 7828098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.
    Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD
    Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety and immunogenicity of a new inactivated hepatitis A vaccine].
    Ren A; Ma J; Feng F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):357-9. PubMed ID: 11986726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
    D'Acremont V; Herzog C; Genton B
    J Travel Med; 2006; 13(2):78-83. PubMed ID: 16553593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
    Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind study in healthy adults to assess the boosting effect of Vaqta or Havrix after a single dose of Havrix.
    Connor BA; Phair J; Sack D; McEniry D; Hornick R; Banerjee D; Jensen E; Kuter B
    Clin Infect Dis; 2001 Feb; 32(3):396-401. PubMed ID: 11170947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial.
    Mayorga Pérez O; Herzog C; Zellmeyer M; Loáisiga A; Frösner G; Egger M
    J Infect Dis; 2003 Sep; 188(5):671-7. PubMed ID: 12934183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis A vaccines.
    Nothdurft HD
    Expert Rev Vaccines; 2008 Jul; 7(5):535-45. PubMed ID: 18564009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hepatitis A infections: guidelines for use of hepatitis A vaccine and immune globulin. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1996 Dec; 98(6 Pt 1):1207-15. PubMed ID: 8951284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A vaccine in the last-minute traveler.
    Connor BA
    Am J Med; 2005 Oct; 118 Suppl 10A():58S-62S. PubMed ID: 16271543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.